A detailed history of Legato Capital Management LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Legato Capital Management LLC holds 63,045 shares of NPCE stock, worth $809,497. This represents 0.08% of its overall portfolio holdings.

Number of Shares
63,045
Previous 21,722 190.24%
Holding current value
$809,497
Previous $241,000 173.03%
% of portfolio
0.08%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$8.25 - $10.6 $340,914 - $438,023
41,323 Added 190.24%
63,045 $658,000
Q2 2025

Aug 14, 2025

SELL
$10.34 - $18.13 $200,440 - $351,450
-19,385 Reduced 47.16%
21,722 $241,000
Q1 2025

May 06, 2025

BUY
$10.04 - $14.94 $412,714 - $614,138
41,107 New
41,107 $505,000

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $319M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.